Stocks to sell

Despite a decline of nearly 10% from June 21 through June 25, MicroVision (NASDAQ:MVIS) remains a Reddit stock winner in 2021. As I write this article, MVIS stock is up over 178% for the year. It’s hard to argue that retail investors haven’t been successful. Their conviction — and short interest that sits around 17%

Any time I write about meme stocks, I like to distinguish between trading and investing. I have no idea where AMC Entertainment (NYSE:AMC) will trade next week or next month. If you are YOLOing on AMC stock the same way you’s bet on a horse at the Kentucky Derby, this story is not for you.

I’ve been a big fan of bank stocks for years. This is mainly due to their humble valuations. All the major ones are of great quality yet have been cheap for far too long. By saying that, a reader would presume that I am writing positively about the upside opportunity in Bank of America (NYSE:BAC)

Given Organon & Co’s (NYSE:OGN) low growth, its sizeable competition, its lack of concrete positive catalysts, and the fact that its management plans to institute an average dividend in the future, I urge investors to avoid OGN stock for now. Source: Shutterstock Moreover, although Organon says that it’s looking to make acquisitions, its relatively low

There’s an argument to be made that all of the recent movement in Orphazyme (NASDAQ:ORPH) is simply a sign of the times. Even if it isn’t, there’s little reason to invest in ORPH stock now. That’s because the recent price spikes and subsequent shareholder announcements were little more than bets. Source: Shutterstock Before the spike,

MindMed (NASDAQ:MNMD) is a neuro-pharmaceutical company that specializes in psychedelic medicine. It discovers, develops and deploys these products to improve health, promote wellness and alleviate suffering. MNMD stock spiked after its initial public offering (IPO) in April, but has cooled since. Source: Shutterstock Is this a buying opportunity, or should investors steer clear of the stock? If

FinTech leader SoFi Technologies (NASDAQ:SOFI) recently completed its merger with special purpose acquisition company (SPAC) Social Capital Hedosophia V. This caused IPOE stock to convert into SOFI stock, beginning SoFi’s official run as a publicly traded company. Source: rafapress / Shutterstock.com SoFi was an impressive merger partner for the “King of SPACs,” Chamath Palihapitiya. The private

Self-billed as one of the largest e-commerce marketplaces in the world, I can fundamentally appreciate the bullish catalyst supporting Contextlogic (NASDAQ:WISH) today. Particularly in the age of the novel coronavirus, online businesses offer tremendous appeal. That said, most speculators probably aren’t thinking about the fundamentals when it comes to WISH stock. Source: sdx15 / Shutterstock.com

One of the more controversial electric vehicle start-up companies on the market is Nikola (NASDAQ:NKLA). Source: Stephanie L Sanchez / Shutterstock.com NKLA became public through a reverse merger back in June 2020, with a SPAC called VectorIQ Holdings. Red flags popped up almost immediately ranging from a suspicious test roll out in 2020 to a

After bottoming at below $10 last month, Workhorse Group (NASDAQ:WKHS) caught the eye of Reddit’s WallStreetBets. WKHS stock has a short interest of almost 40%. The subreddit group reasons that a short-squeeze would inflect big losses for bears. So, when Workhorse shares took a run for $20, the rally would last until buyers lost momentum.

As of this writing, the latest meme stock rally in ContextLogic (NASDAQ:WISH) stock appears to be running out of gas. Source: sdx15 / Shutterstock.com Starting June 1, this favorite of Reddit’s r/WallStreetBets subreddit, zoomed from $7.74 per share, to prices topping $15 per share. But, after falling to $14.93 on June 29, it may be

After a number of data points emerged that are negative for DraftKings (NASDAQ:DKNG) stock, I remain bearish on the shares. DraftKings’ Q1 bottom line was quite worrisome, while its valuation is sky-high. In several past columns, my thesis has been that the U.S. sports gambling market would be hyper-competitive. Validating that thesis is a report

Is there still hope for Ocugen (NASDAQ:OCGN)? Or are the OCGN stock bulls just delusional? In my view, you can count on the latter. Any way you slice it, this biotech company has little chance of generating big profits — or even big sales — from its Covaxin Covid-19 vaccine candidate. Source: Shutterstock As you

Clean Energy Fuels (NASDAQ:CLNE) reminds me of another company that briefly became extremely popular among retail investors: Gevo (NASDAQ:GEVO). The shares of both GEVO stock and CLNE stock are now about 50% off their 52-week highs and have generated mediocre returns in recent weeks , as many investors apparently started to realize that neither of

After losing its luster this spring and declining sharply, Tesla (NASDAQ:TSLA) stock is struggling to get back in the good books with investors. Source: Grisha Bruev / Shutterstock.com Year-to-date, TSLA stock is down 7% at its current price of  around $679 a share. The company’s stock is 24% below its 52-week high of $900 reached

Lordstown Motors (NASDAQ:RIDE) stock is becoming a cautionary tale for many investors in electric vehicle (EV) stocks. Source: Postmodern Studio / Shutterstock.com RIDE stock is down almost 50% in 2021. And that was the case before the company announced that its “backlog” of pre-orders do not represent binding commitment.   That announcement came on the heels of top

The outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks, but given the cruise operator’s extremely high debt load and the great amount of uncertainty it continues to face, I still urge investors to sell their shares. Source: Ruth Peterkin / Shutterstock.com In addition to its highly elevated debt load, Carnival must deal

At just under $60 per share, what’s the play with AMC Entertainment (NYSE:AMC) stock? Is it a buy? Not so fast. Source: viewimage / Shutterstock.com Sure, retail speculators, led by Reddit’s r/WallStreetBets, have so far prevailed against the so-called “smart money” short sellers. On the other hand, in terms of underlying value and long-term prospects,

The party’s over once again for Clover Health (NASDAQ:CLOV) stock. A few months back, the insurtech company, and former SPAC (special purpose acquisition company), was a popular health care-related “story stock.” Source: Shutterstock News of a Department of Justice (DOJ) investigation fueled a big change in investor’s opinions about it. But starting in the spring,

ContextLogic (NASDAQ:WISH) stock went public last December. After a brief pop, the share price fell to single digits in May. Source: sdx15 / Shutterstock.com It fell because ContextLogic loses money. Its first quarter report showed a loss of $128 million, 21 cents per share, on revenue of $772 million. Losses from operations, $126 million, grew